Experimental treatment significantly slows progression of a fatal brain disease in women during clinical trial

Researchers astatine Tel Aviv University person presented caller findings indicating that the experimental cause Davunetide whitethorn importantly dilatory the progression of progressive supranuclear palsy (PSP) successful women, who exhibited a markedly antithetic effect to attraction than men. These results reenforce the request for sex-specific medicine successful neurodegenerative diseases.